NCT04521686 2025-06-27Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT00405405 2025-05-06Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerThomas Jefferson UniversityPhase 1 Completed13 enrolled